401 related articles for article (PubMed ID: 17716143)
1. Radical nanomedicine.
Rzigalinski BA; Meehan K; Davis RM; Xu Y; Miles WC; Cohen CA
Nanomedicine (Lond); 2006 Dec; 1(4):399-412. PubMed ID: 17716143
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic functions of antioxidant nanoparticles for longevity and medicine.
Narayanan KB; Park HH
Adv Colloid Interface Sci; 2013 Dec; 201-202():30-42. PubMed ID: 24206941
[TBL] [Abstract][Full Text] [Related]
3. Treatment of neurodegenerative disorders with radical nanomedicine.
Singh N; Cohen CA; Rzigalinski BA
Ann N Y Acad Sci; 2007 Dec; 1122():219-30. PubMed ID: 18077575
[TBL] [Abstract][Full Text] [Related]
4. Characterization of nanoparticles for therapeutics.
Hall JB; Dobrovolskaia MA; Patri AK; McNeil SE
Nanomedicine (Lond); 2007 Dec; 2(6):789-803. PubMed ID: 18095846
[TBL] [Abstract][Full Text] [Related]
5. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
Son SJ; Bai X; Lee SB
Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine and veterinary science: the reality and the practicality.
Underwood C; van Eps AW
Vet J; 2012 Jul; 193(1):12-23. PubMed ID: 22365842
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant nanoparticles for control of infectious disease.
Elswaifi SF; Palmieri JR; Hockey KS; Rzigalinski BA
Infect Disord Drug Targets; 2009 Aug; 9(4):445-52. PubMed ID: 19689385
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
Ilinskaya AN; Dobrovolskaia MA
Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264
[TBL] [Abstract][Full Text] [Related]
9. Reactive Oxygen Species (ROS)-Based Nanomedicine.
Yang B; Chen Y; Shi J
Chem Rev; 2019 Apr; 119(8):4881-4985. PubMed ID: 30973011
[TBL] [Abstract][Full Text] [Related]
10. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications.
Son SJ; Bai X; Lee SB
Drug Discov Today; 2007 Aug; 12(15-16):657-63. PubMed ID: 17706548
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological potential of cerium oxide nanoparticles.
Celardo I; Pedersen JZ; Traversa E; Ghibelli L
Nanoscale; 2011 Apr; 3(4):1411-20. PubMed ID: 21369578
[TBL] [Abstract][Full Text] [Related]
12. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
Al-Jamal WT; Kostarelos K
Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
[TBL] [Abstract][Full Text] [Related]
13. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
Al-Jamal WT; Kostarelos K
Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
[TBL] [Abstract][Full Text] [Related]
14. Theranostic nanoparticles engineered for clinic and pharmaceutics.
Ma X; Zhao Y; Liang XJ
Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
[TBL] [Abstract][Full Text] [Related]
15. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
Fadeel B; Garcia-Bennett AE
Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
[TBL] [Abstract][Full Text] [Related]
16. Integration column: biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications.
Rothenfluh DA; Hubbell JA
Integr Biol (Camb); 2009 Jul; 1(7):446-51. PubMed ID: 20023754
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology in cardiovascular medicine.
Patel DN; Bailey SR
Catheter Cardiovasc Interv; 2007 Apr; 69(5):643-54. PubMed ID: 17390307
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle therapeutics: a personal perspective.
McNeil SE
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):264-71. PubMed ID: 20049796
[TBL] [Abstract][Full Text] [Related]
19. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
[TBL] [Abstract][Full Text] [Related]
20. Surface-active liposomes for targeted cancer therapy.
Sofou S
Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
